Indwelling catheter with stable enzyme coating

• US 5,788,678 A
• Filed: 11/13/1995
• Issued: 08/04/1998
• Est. Priority Date: 04/01/1994
• Status: Expired due to Term

• Current Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Original Assignee: Minimed, Inc. (Medtronic Plc)
• Inventors: Van Antwerp, William P.
• Primary Examiner(s): Buiz, Michael Powell
• Assistant Examiner(s): Mehta, Bhisma
• Application Number:
  US08/557,408
• Time in Patent Office: 995 Days
• Field of Search: 604/264, 604/265, 604/266, 604/890.1, 604/891.1, 604/892.1, 424/422, 424/423, 424/426, 424/499, 435/177, 435/178, 435/180, 427/2.12, 427/2.28, 427/2.3
• US Class Current: 604/265
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61M 25/0017 specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections

Abstract

An improved indwelling catheter adapted for long-term usage includes a stable enzyme coating to prevent occlusion of the catheter lumen. The enzyme coating includes a fibrinolytic and/or lipolytic enzyme incorporated in a catheter coating to resist or control proteolytic degradation, thereby maintaining the enzyme in an active state for dissolving clots and occlusions within the catheter lumen over an extended period of time.

Claims

1. A catheter, comprising:

an elongated tubular element formed from a polymeric material and adapted for patient placement, said tubular element defining a catheter lumen, and

a surface coating applied to said tubular element on at least a portion of the surface thereof, said surface coating including at least one enzyme effective to dissolve occlusions along said catheter lumen, said at least one enzyme comprising a lipolytic enzyme, and means for protecting said enzyme against short-term degradation upon contact with patient body fluids;

said surface coating comprising time release capsules having the enzyme contained within an encapsulant shell of a material soluble in the presence of patient body fluids, said capsules having a variable shell thickness for dissolution in the presence of body fluids, to expose the enzyme therein over an extended period of time.

2. The catheter of claim 1 wherein said at least one enzyme comprises a combination of fibrinolytic and lipolytic enzymes.

3. The catheter of claim 1 further including means for bonding said capsules to said tubular element.

4. The catheter of claim 1 wherein said encapsulant shell comprises a soluble starch.

5. The catheter of claim 1 wherein said encapsulant shell of said capsules has a variable shell thickness within the range of from about 0.2 to about 7.0 microns.

9. The catheter of claim 1 wherein said at least one enzyme comprises phospholipase.

6. A method of applying an enzyme coating to a polymeric catheter, said method comprising the steps of:

forming time release capsules each having at least one lipolytic enzyme within an encapsulant shell of a material hydrolyzable in the presence of patient body fluids, and wherein the capsule shells have a variable shell thickness; and

bonding the time release capsules to at least a portion of the surface of the catheter.

7. The method of claim 6 wherein said bonding step comprises coating the capsules with a bonding agent adapted for secure bonding to the catheter, and contacting the coated capsules with the catheter.

8. The method of claim 6 wherein said bonding step comprises coating the capsules and at least a portion of the surface of the catheter with different silane compounds adapted to covalently bond with each other, and contacting the coated capsules with the coated catheter to bond capsules with respect to the catheter.

10. An in vivo medical device, comprising:

a substrate formed from a polymeric material and adapted for in vivo patient placement; and

at least one enzyme on at least a portion of the surface of said substrate, said enzyme being effective in the presence of patient body fluids to dissolve lipid-based occlusions on said substrate.

11. The medical device of claim 10 further including means for protecting said enzyme against short-term degradation upon contact with patient body fluids.

12. The medical device of claim 11 wherein said protecting means comprises time release capsules having the enzyme contained within an encapsulant shell of a material soluble in the presence of patient body fluids, said capsules having a variable shell thickness for dissolution in the presence of body fluids to expose the enzyme therein over an extended period of time.

13. The medical device of claim 10 wherein said at least one enzyme comprises a combination of fibrinolytic and lipolytic enzymes.

14. The medical device of claim 10 wherein said enzyme comprises phosphoslipase.